Citations (38)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Andries H. Groen, Jacob A. de Ru, Cindy Postma, Gerben E. Breimer & Johannes A. Rijken. (2023) Oral cavity cancer in two young patients with ulcerative colitis, a case report. Acta Oto-Laryngologica Case Reports 8:1, pages 108-112.
Read now
Read now
Yiting Luo, Jin Wu, Yingchao Liu, Yan Shen, Fangyuan Zhu, Jiaqian Wu & Yuyao Hu. (2022) Metabolomics Study of Shaoyao Plants Decoction on the Proximal and Distal Colon in Mice with Dextran Sulfate Sodium-Induced Colitis by UPLC-Q-TOF-MS. Drug Design, Development and Therapy 16, pages 4343-4364.
Read now
Read now
HongQian Wang, Xue He, ShiMin Liang & Xi Chen. (2022) Role of vitamin D in ulcerative colitis: an update on basic research and therapeutic applications. Expert Review of Gastroenterology & Hepatology 16:3, pages 251-264.
Read now
Read now
Yong Cao, Yan Lin, Yan Sun, Weiyu Liu, Yichuan Shao & Changqing Zheng. (2021) Fenretinide regulates macrophage polarization to protect against experimental colitis induced by dextran sulfate sodium. Bioengineered 12:1, pages 151-161.
Read now
Read now
Roberta Roberti, Luigi Francesco Iannone, Caterina Palleria, Caterina De Sarro, Rocco Spagnuolo, Maria Antonietta Barbieri, Ada Vero, Antonia Manti, Valentina Pisana, Walter Fries, Gianluca Trifirò, Maria Diana Naturale, Tiziana Larussa, Adele Emanuela De Francesco, Vincenzo Bosco, Eugenio Donato di Paola, Rita Citraro, Francesco Luzza, Luigi Bennardo, Stefano Rodinò, Patrizia Doldo, Edoardo Spina, Emilio Russo & Giovambattista De Sarro. (2020) Safety profiles of biologic agents for inflammatory bowel diseases: a prospective pharmacovigilance study in Southern Italy. Current Medical Research and Opinion 36:9, pages 1457-1463.
Read now
Read now
Shi Liu, Hui Shen, Jiyan Li, Ying Gong, Haidong Bao, Jingyuan Zhang, Lanqing Hu, Zhengpeng Wang & Jian Gong. (2020) Loganin inhibits macrophage M1 polarization and modulates sirt1/NF-κB signaling pathway to attenuate ulcerative colitis. Bioengineered 11:1, pages 628-639.
Read now
Read now
Articles from other publishers (32)
Xin Chen, Charles O Elson & David Dunkin. (2023) Epicutaneous Immunotherapy with CBir1 Alleviates Intestinal Inflammation. Inflammatory Bowel Diseases 29:5, pages 798-807.
Crossref
Crossref
Gabriele Dragoni, Fabiana Castiglione, Cristina Bezzio, Daniela Pugliese, Rocco Spagnuolo, Anna Viola, Francesco Cocomazzi, Annalisa Aratari, Edoardo Vincenzo Savarino, Paola Balestrieri, Sara Onali, Chiara Viganò, Davide Giuseppe Ribaldone, Tommaso Innocenti, Anna Testa, Simone Saibeni, Giuseppe Privitera, Monica Milla, Alessandro Armuzzi, Massimo Claudio Fantini & Gionata Fiorino. (2023) Comparison of two strategies for the management of postoperative recurrence in Crohn’s disease patients with one clinical risk factor: A multicentre IG‐IBD study. United European Gastroenterology Journal 11:3, pages 271-281.
Crossref
Crossref
Hye-Jung Moon, Youn-Soo Cha & Kyung-Ah Kim. (2023) Blackcurrant Alleviates Dextran Sulfate Sodium (DSS)-Induced Colitis in Mice. Foods 12:5, pages 1073.
Crossref
Crossref
Robert Ehehalt & Franz Hartmann. 2023. Pflege bei chronisch-entzündlichen Darmerkrankungen. Pflege bei chronisch-entzündlichen Darmerkrankungen
113
129
.
Darja Urlep & Erasmo Miele. 2023. Pediatric Inflammatory Bowel Disease. Pediatric Inflammatory Bowel Disease
391
399
.
Medea Salzmann, Thea von Graffenried, Franziska Righini-Grunder, Christian Braegger, Johannes Spalinger, Susanne Schibli, Alain Schoepfer, Andreas Nydegger, Valérie Pittet & Christiane Sokollik. (2022) Drug-Related Adverse Events Necessitating Treatment Discontinuation in Pediatric Inflammatory Bowel Disease Patients. Journal of Pediatric Gastroenterology & Nutrition 75:6, pages 731-736.
Crossref
Crossref
Martina Tallarico, Caterina Palleria, Livia Ruffolo, Rocco Spagnuolo, Maria Diana Naturale, Adele Emanuela De Francesco, Caterina De Sarro, Rossella Romeo, Rita Citraro, Patrizia Doldo, Ludovico Abenavoli, Luca Gallelli, Francesco Luzza, Antonio Leo & Giovambattista De Sarro. (2022) Biologics for Inflammatory Bowel Disease in Clinical Practice: A Calabria (Southern Italy) Prospective Pharmacovigilance Study. Pharmaceutics 14:11, pages 2449.
Crossref
Crossref
E H J Savelkoul, M H J Maas, A R Bourgonje, F Crouwel, V B C Biemans, N den Broeder, M G V M Russel, T E H Römkens, N K de Boer, G Dijkstra & F Hoentjen. (2022) Favourable Tolerability and Drug Survival of Tioguanine Versus Methotrexate After Failure of Conventional Thiopurines in Crohn’s Disease. Journal of Crohn's and Colitis 16:9, pages 1372-1379.
Crossref
Crossref
David Thein, Alexander Egeberg, Lone Skov & Nikolai Loft. (2022) Absolute and Relative Risk of New-Onset Psoriasis Associated With Tumor Necrosis Factor-α Inhibitor Treatment in Patients With Immune-Mediated Inflammatory Diseases. JAMA Dermatology 158:9, pages 997.
Crossref
Crossref
Gajanan D. Katkar, Ibrahim M. Sayed, Mahitha Shree Anandachar, Vanessa Castillo, Eleadah Vidales, Daniel Toobian, Fatima Usmani, Joseph R. Sawires, Geoffray Leriche, Jerry Yang, William J. Sandborn, Soumita Das, Debashis Sahoo & Pradipta Ghosh. (2022) Artificial intelligence-rationalized balanced PPARα/γ dual agonism resets dysregulated macrophage processes in inflammatory bowel disease. Communications Biology 5:1.
Crossref
Crossref
Ganit Goren, Doron Schwartz, Michael Friger, Hagar Banai, Ruslan Sergienko, Shirley Regev, Heba Abu-Kaf, Dan Greenberg, Anna Nemirovsky, Karny Ilan, Livnat Lerner, Alon Monsonego, Iris Dotan, Henit Yanai, Rami Eliakim, Shomron Ben Horin, Vered Slonim-Nevo, Shmuel Odes & Orly Sarid. (2022) Randomized Controlled Trial of Cognitive-Behavioral and Mindfulness-Based Stress Reduction on the Quality of Life of Patients With Crohn Disease. Inflammatory Bowel Diseases 28:3, pages 393-408.
Crossref
Crossref
María José García, Juan Carlos Rodríguez-Duque, Marta Pascual, Coral Rivas, Beatriz Castro, Sandra Raso, Marcos López-Hoyos, María Teresa Arias-Loste & Montserrat Rivero. (2022) Prevalence of antinuclear antibodies in inflammatory bowel disease and seroconversion after biological therapy. Therapeutic Advances in Gastroenterology 15, pages 175628482210778.
Crossref
Crossref
Stella Karsten, Roland Fiskesund, Xing-Mei Zhang, Petra Marttila, Kumar Sanjiv, Therese Pham, Azita Rasti, Lars Bräutigam, Ingrid Almlöf, Maritha Marcusson-Ståhl, Carolina Sandman, Björn Platzack, Robert A. Harris, Christina Kalderén, Karin Cederbrant, Thomas Helleday & Ulrika Warpman Berglund. (2021) MTH1 as a target to alleviate T cell driven diseases by selective suppression of activated T cells. Cell Death & Differentiation 29:1, pages 246-261.
Crossref
Crossref
Lingling Qv, Sunbing Mao, Yongjun Li, Jia Zhang & Lanjuan Li. (2021) Roles of Gut Bacteriophages in the Pathogenesis and Treatment of Inflammatory Bowel Disease. Frontiers in Cellular and Infection Microbiology 11.
Crossref
Crossref
Eirini Theodoraki, Eleni Orfanoudaki, Kalliopi Foteinogiannopoulou, Evangelia Legaki, Maria Gazouli & Ioannis E. Koutroubakis. (2021) Is there a correlation between infliximab trough levels and the development of adverse events in patients with inflammatory bowel disease?. Intestinal Research 19:4, pages 461-467.
Crossref
Crossref
Kathy Weisel, Nicola Scott, Scott Berger, Susanne Wang, Kurt Brown, Marcy Powell, Matthijs Broer, Clarissa Watts, Debra J Tompson, Susan W Burriss, Simon Hawkins, Kathy Abbott-Banner & Paul Peter Tak. (2021) A randomised, placebo-controlled study of RIPK1 inhibitor GSK2982772 in patients with active ulcerative colitis. BMJ Open Gastroenterology 8:1, pages e000680.
Crossref
Crossref
Li Gu, Feng Ren, Xianrui Fang, Lianwen Yuan, Ganglei Liu & Shalong Wang. (2021) Exosomal MicroRNA-181a Derived From Mesenchymal Stem Cells Improves Gut Microbiota Composition, Barrier Function, and Inflammatory Status in an Experimental Colitis Model. Frontiers in Medicine 8.
Crossref
Crossref
T Kucharzik, P Ellul, T Greuter, J F Rahier, B Verstockt, C Abreu, A Albuquerque, M Allocca, M Esteve, F A Farraye, H Gordon, K Karmiris, U Kopylov, J Kirchgesner, E MacMahon, F Magro, C Maaser, L de Ridder, C Taxonera, M Toruner, L Tremblay, M Scharl, N Viget, Y Zabana & S Vavricka. (2021) ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammatory Bowel Disease. Journal of Crohn's and Colitis 15:6, pages 879-913.
Crossref
Crossref
Honggang Chi, Dan Wang, Mengting Chen, Jiantao Lin, Shuhua Zhang, Fengyan Yu, Jun Zhou, Xuebao Zheng & Ying Zou. (2021) Shaoyao Decoction Inhibits Inflammation and Improves Intestinal Barrier Function in Mice With Dextran Sulfate Sodium-Induced Colitis. Frontiers in Pharmacology 12.
Crossref
Crossref
Shirley Cohen-Mekelburg, Beth I. Wallace, Tony Van, Wyndy L. Wiitala, Shail M. Govani, Jennifer Burns, Rachel Lipson, Huifeng Yun, Jason Hou, James D. Lewis, Jason A. Dominitz & Akbar K. Waljee. (2021) Association of Anti–Tumor Necrosis Factor Therapy With Mortality Among Veterans With Inflammatory Bowel Disease. JAMA Network Open 4:3, pages e210313.
Crossref
Crossref
Ana Paula da Fonseca Machado, Marina Vilar Geraldi, Roberto de Paula do Nascimento, Amanda Maria Tomazini Munhoz Moya, Teresa Vezza, Patricia Diez-Echave, Julio Juan Gálvez, Cinthia Bau Betim Cazarin & Mário Roberto Maróstica Júnior. (2021) Polyphenols from food by-products: An alternative or complementary therapy to IBD conventional treatments. Food Research International 140, pages 110018.
Crossref
Crossref
Yi Yin, Jingjing Yang, Yongchun Pan, Yanfeng Gao, Liangyu Huang, Xiaowei Luan, Zhengfan Lin, Weiming Zhu, Yi Li & Yujun Song. (2020) Mesopore to Macropore Transformation of Metal–Organic Framework for Drug Delivery in Inflammatory Bowel Disease. Advanced Healthcare Materials 10:3, pages 2000973.
Crossref
Crossref
Gabor Tajti, Dorothy C.C. Wai, Gyorgy Panyi & Raymond S. Norton. (2020) The voltage-gated potassium channel KV1.3 as a therapeutic target for venom-derived peptides. Biochemical Pharmacology 181, pages 114146.
Crossref
Crossref
Fernando Magro, Gonçalo Cordeiro, Andreia Martins Dias & Maria Manuela Estevinho. (2020) Inflammatory Bowel Disease – Non-biological treatment. Pharmacological Research 160, pages 105075.
Crossref
Crossref
Ashley Vachon & Frank I. Scott. (2020) The treatment approach to inflammatory bowel disease in 2020. Current Opinion in Gastroenterology 36:4, pages 247-256.
Crossref
Crossref
Tiziana Larussa, Evelina Suraci, Raffaella Marasco, Maria Imeneo, Dan L. Dumitrascu, Ludovico Abenavoli & Francesco Luzza. (2020) Barriers and Facilitators in Conducting Clinical Trials in Inflammatory Bowel Disease: A Monocentric Italian Survey. Reviews on Recent Clinical Trials 15:2, pages 137-144.
Crossref
Crossref
Xiangqi Li, Chaobao Zhang, Lianyong Liu & Mingjun Gu. (2020) Existing bitter medicines for fighting 2019‐nCoV‐associated infectious diseases. The FASEB Journal 34:5, pages 6008-6016.
Crossref
Crossref
Vicente Martínez, Amaia Iriondo De-Hond, Francesca Borrelli, Raffaele Capasso, María Dolores del Castillo & Raquel Abalo. (2020) Cannabidiol and Other Non-Psychoactive Cannabinoids for Prevention and Treatment of Gastrointestinal Disorders: Useful Nutraceuticals?. International Journal of Molecular Sciences 21:9, pages 3067.
Crossref
Crossref
Carlos Walter Sobrado, Natália Sousa Freitas Queiroz & Caio Almeida Perez. 2020. Biological Therapy for Inflammatory Bowel Disease. Biological Therapy for Inflammatory Bowel Disease.
Glen S. Hazlewood, Gyanendra Pokharel, Robert Deardon, Deborah A. Marshall, Claire Bombardier, George Tomlinson, Christopher Ma, Cynthia H. Seow, Remo Panaccione & Gilaad G. Kaplan. (2020) Patient preferences for maintenance therapy in Crohn’s disease: A discrete-choice experiment. PLOS ONE 15:1, pages e0227635.
Crossref
Crossref
Donatella Volpatti, Eleonora Gulisano & Mauro Spanghero. (2019) Short note: Infliximab recovery in a simulated intestinal fluid of the upper intestine tract. Human Antibodies 27:4, pages 241-246.
Crossref
Crossref
Sruthi Vijaya Retnakumar & Sylviane Muller. (2019) Pharmacological Autophagy Regulators as Therapeutic Agents for Inflammatory Bowel Diseases. Trends in Molecular Medicine 25:6, pages 516-537.
Crossref
Crossref